Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study
Fecha de publicación
2013Título de revista
Journal Of Clinical Oncology
Tipo de contenido
Publicación de congreso